Protein S human

DB13149ApprovedInvestigationalProtein Based Therapies

Protein S human is a medication used for emergency reversal of coagulation factor deficiency in vitamin K antagonist therapy. Protein S human is a vitamin K-dependent plasma glycoprotein which has antcoagulant properties.

Protein structure of Protein S human
Mechanism
Curator reviewed · 6 references
Primary indication
Protein S is administered as part of a cocktail containing several other coagulation factors.Curator reviewed · 1 structured indication
Formula / weight
75123.0 Da
First approval
Canada, 2007 · United States, 2013
Also known as
Protein S · Protein S (human) · Vitamin K-dependent protein S
Brand names
  • Balfaxar
  • Beriplex
  • Kcentra
  • Octaplex

Resolves to

Clinical / RWD

What you can answer from here — as of June 15, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
647Drug interactionsStructured to mechanism, not free text
Sign in
18Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
17Marketed productsAcross 6 countries and 7 labellers
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Protein S human, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account